Researchers Seek Biomarkers to Predict ATYR1923’s Effectiveness

Researchers Seek Biomarkers to Predict ATYR1923’s Effectiveness

304370

Researchers Seek Biomarkers to Predict ATYR1923’s Effectiveness

aTyr Pharma has announced a collaboration with The Ohio State University (OSU) to conduct cell culture studies seeking to identify potential biomarkers that can predict ATYR1923’s therapeutic effectiveness in people with pulmonary sarcoidosis. The research, which extends previous proof-of-concept findings, will delineate the pathways involved in sarcoid granuloma formation and evaluate the effect of ATYR1923 on granuloma formation in cell cultures (in vitro) of blood samples taken from people with sarcoidosis. Recommended Reading August 5, 2021…

You must be logged in to read/download the full post.